Glutathione may interact with certain medications metabolized via glutathione conjugation, and excessive antioxidant activity can theoretically blunt beneficial inflammatory signaling during metabolic adaptation
Sources & References Eli Lilly press release: Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C
Have been using the weight loss injections for about 3 months and have lost over 5kg with hardly any exercise as I'm disabled so can't really exercise
It is important to contextualise these results carefully: Phase 2 trials involve relatively small, controlled populations and are not sufficient on their own to establish a medicine's full safety profile or its suitability for broad clinical use
This regulatory role is particularly pronounced in disease states such as diabetes and cancer, highlighting the importance of GPER in cellular energy metabolism [219]
The US State Department website provides contact information for foreign embassies, and many countries maintain dedicated customs or health ministry websites with medication importation guidelines